116 results
Page 2 of 6
8-K
EX-10.1
qf3n3gyh5x2om
10 Jan 22
EyePoint Pharmaceuticals Appoints Michael C. Pine as Chief Corporate Development and Strategy Officer
4:31pm
8-K
EX-10.1
aas 9bqbrethb99dy2
1 Nov 21
EyePoint Pharmaceuticals Appoints
7:05am
8-K
EX-10.1
zfccnloyu9t7btb43
24 Jun 21
Termination of a Material Definitive Agreement
6:03am
8-K
EX-10.2
lf26yvxtb3ph z7e2y8
24 Jun 21
Termination of a Material Definitive Agreement
6:03am
8-K
EX-10.1
9574z45hn3qcuw7s52dq
3 Feb 21
Entry into a Material Definitive Agreement
4:11pm
8-K
EX-10.1
nh3mgnz v3ugqdbr
4 Jan 21
EyePoint Pharmaceuticals Announces $15.7 Million Equity Investment by Asia Partner Ocumension Therapeutics
6:12am
8-K
EX-10.2
tlsl5 776mn
4 Jan 21
EyePoint Pharmaceuticals Announces $15.7 Million Equity Investment by Asia Partner Ocumension Therapeutics
6:12am
8-K
EX-10.1
y8r37 755da
8 Oct 20
EyePoint Pharmaceuticals Announces Amendment to CRG Debt Facility Modifying 2020 and 2021 Revenue Covenants
7:05am